RIL
INMB icon

Rothschild Investment LLC’s INmune Bio INMB Stock Holding History

Rothschild Investment LLC’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$505 Sell
310
-275
-47% -$380 ﹤0.01% 3263
2026
Q1 		$661 Buy
+585
New +$834 ﹤0.01% 3028
2025
Q3 		– Sell
-30
Closed -$69 – 3196
2025
Q2 		$69 Hold
30
– – ﹤0.01% 2992
2025
Q1 		$234 Hold
30
– – ﹤0.01% 2817
2024
Q4 		$140 Buy
+30
New +$156 ﹤0.01% 2856

Other funds holding INMB

CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
FPAS
Focus Partners Advisor Solutions Saint Louis, Missouri $11.8B AUM 25.68% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Rothschild Investment LLC's INMB Position: Q2 2026 in Review

Rothschild Investment LLC reduced its INmune Bio (INMB) stake by 47% in Q2 2026, selling an estimated $380 and leaving 310 shares worth $505. The position accounts for ﹤0.01% of the portfolio, ranked #3263.

Rothschild Investment LLC first reported a position in INMB in Q4 2024 and has held it in 5 quarters since. The position peaked at $661 in Q1 2026. 26 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • Rothschild Investment LLC held 310 shares of INmune Bio worth $505 as of Q2 2026.
  • Rothschild Investment LLC sold 275 INmune Bio shares in Q2 2026, an estimated $380.
  • INmune Bio made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3263 holding.
  • Rothschild Investment LLC first reported a position in INmune Bio in Q4 2024 and has held it in 5 quarters since.
  • Rothschild Investment LLC's INmune Bio position peaked at $661 in Q1 2026.
  • 26 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.